Ilkka Kantola

Evaluating enzyme replacement therapy in Fabry diease (2010)

Archives of Internal Medicine -New Series-

Koskenvuo JW, Kantola IM

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

The choice of home bood pressure result reporting method is essential: Results mailed to physicians did not improve hypertension control compared with ordinary office-based blood pressure treatment (2010)

Blood Pressure

Varis J, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Efficacy and safety of angiotensin receptor blockade are not mobified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme (2010)

European Journal of Heart Failure

Chang SM, Cranger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME, CHARM Investigators, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial (2010)

Lancet

Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA, ACCOMPLISH Trial Investigators, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Diabeetikon käsi- ja nivelmuutokset (2010)

Lääkärilehti

Arkkila P, Viikari J, Kantola I

(Artikkeli ammattilehdessä tai kirjoitus ammatillisessa blogissa (D1))

Fabry disease: a review of current management strategies (2010)

QJM: An International Journal of Medicine

Mehta A, Beck M, Eyskens F, Feliciani C, Kantola I, Ramaswami U, Rolfs A, Rivera A, Waldek S, Germain DP

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial (2010)

International Journal of Clinical Practice

Lindgren P, Eriksson J, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B, ASCOT Trial investigators, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme (2010)

European Journal of Heart Failure

Hawkins NM, Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Ostergren J, Michelson EL, Pocock SJ, Maggion AP, McMurray JJ, CHARM Investigators and Committees, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan; rampril; or both:(ONTARGET/TRANSCEND)Trials (2010)

Circulation

Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S, ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The assessment of total cardiovascular risk in hypertensive subjects in primary care (2010)

Annals of Medicine

Korhonen P, Vesalainen R, Aarnio P, Saaresranta T, Kautiainen H, Järvenpää S, Kantola I

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Evaluating enzyme replacement therapy in Fabry diease (2010)

The choice of home bood pressure result reporting method is essential: Results mailed to physicians did not improve hypertension control compared with ordinary office-based blood pressure treatment (2010)

Efficacy and safety of angiotensin receptor blockade are not mobified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme (2010)

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial (2010)

Diabeetikon käsi- ja nivelmuutokset (2010)

Fabry disease: a review of current management strategies (2010)

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial (2010)

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme (2010)

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan; rampril; or both:(ONTARGET/TRANSCEND)Trials (2010)

The assessment of total cardiovascular risk in hypertensive subjects in primary care (2010)